Arnon Nagler, MD

Experts Arnon Nagler, MD and Maksim Mamonkin, PhD discuss the growing role of immunotherapy in the treatment of B-cell acute lymphoblastic leukemia (B-ALL). They explore the use of novel immunotherapies like CAR-T cells, antibody-drug conjugates, and monoclonal antibodies, as well as the possibility of moving away from stem cell transplantation. Topics covered include targeting CD7 in T-ALL, chemotherapy-free regimens, and the future of ALL treatment.